Family Man. Urology trainee @VattikutiUrol@HenryFordHealth. Culinary enthusiast. PM me if you have a way to make the world a better place to live in. RT≠E.
Annual Research Retreat by @VattikutiCORE: reunion of past members, intro to new ones & ongoing projects. Witnessing the journeys of those who've been a part of this over the years was inspiring! With @DrFAbdollah guidance, eager for future studies from our talks! #VCOREFamily
So proud of @DatguyTinsley @VattikutiUrol@HenryFordHealth - easy to mentor and work with such a hardworking, high energy, intelligent, and generally good guy over the past few years. Watch out for for him. @AmerUrological
Dr. Ray Littleton interviewing Medical Student @DatguyTinsley here at @HenryFordHealth
Fun Fact: @DatguyTinsley was accepted into Medical School directly after High School 👏🏽 AMAZING!
#AUA#Urology
Very excited to go to this grand rounds tomorrow and privileged to work at a program that is deeply rooted in promoting diversity in urology! @VattikutiUrol
‼️Happening this Wednesday‼️
This Grand Rounds event will highlight the contributions of Black Urologists to the history of medicine despite systemic racism in the medical field and across the country. ✨
#AUA#Urology#AUAMembers
‼️Happening this Wednesday‼️
This Grand Rounds event will highlight the contributions of Black Urologists to the history of medicine despite systemic racism in the medical field and across the country. ✨
#AUA#Urology#AUAMembers
Fun resident robotic training lab yesterday on SP and Xi. Special guest of patient who was emotional and grateful to see residents learning robotic techniques that she benefitted from almost a year ago.
Amazing lectures this morning on journey so far and innovations in robotic surgery by visiting professor @drjkaouk@CleClinicUro at @VattikutiUrol@HenryFordHealth graduation. Grateful for his dedication and drive - excited about the future!
Absolutely unbelievable data by @AndreaCercek@MSKCancerCenter at @ASCO#ASCO2022: 100% CR rate in 14 consecutive high risk (90% st3) rectal cancer pts w/ Dostarlimab PD1 monotherapy. NO PATIENT REQUIRED CHEMO/SURGERY/RT. #immunoablative therapy is here published now in @NEJM